home / stock / nrbo / nrbo short
Short Information | NeuroBo Pharmaceuticals Inc. (NASDAQ:NRBO)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 81,455 |
Total Actual Volume | 556,050 |
Short Trends | |
---|---|
Cover Days | 19 |
Short Days | 0 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 4,073 |
Average Short Percentage | 14.78% |
Is there a NRBO Short Squeeze or Breakout about to happen?
See the NRBO Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
05-02-2024 | $3.67 | $3.73 | $3.73 | $3.55 | 14,904 | 3,778 | 25.35% |
05-01-2024 | $3.43 | $3.68 | $3.68 | $3.35 | 60,029 | 6,286 | 10.47% |
04-30-2024 | $3.37 | $3.25 | $3.4499 | $3.245 | 42,244 | 10,937 | 25.89% |
04-29-2024 | $3.2299 | $3.23 | $3.23 | $3.1 | 12,277 | 363 | 2.96% |
04-26-2024 | $3.06 | $3.14 | $3.14 | $3 | 17,307 | 235 | 1.36% |
04-24-2024 | $2.99 | $3.1 | $3.4999 | $2.99 | 39,253 | 6,388 | 16.27% |
04-23-2024 | $3.1 | $3.02 | $3.19 | $2.99 | 42,194 | 2,417 | 5.73% |
04-22-2024 | $3.26 | $3.12 | $3.3 | $3.08 | 23,389 | 1,625 | 6.95% |
04-19-2024 | $3.49 | $3.37 | $3.49 | $3.26 | 20,562 | 1,538 | 7.48% |
04-18-2024 | $3.59 | $3.44 | $3.59 | $3.3534 | 22,788 | 3,787 | 16.62% |
04-17-2024 | $3.69 | $3.46 | $3.69 | $3.46 | 11,485 | 2,137 | 18.61% |
04-16-2024 | $3.615 | $3.4 | $3.615 | $3.33 | 12,946 | 1,285 | 9.93% |
04-15-2024 | $3.61 | $3.53 | $3.73 | $3.49 | 22,921 | 1,691 | 7.38% |
04-12-2024 | $3.58 | $3.61 | $3.95 | $3.58 | 75,652 | 11,746 | 15.53% |
04-11-2024 | $3.69 | $3.58 | $3.69 | $3.56 | 14,708 | 1,789 | 12.16% |
04-10-2024 | $3.55 | $3.56 | $3.6648 | $3.5 | 13,047 | 2,034 | 15.59% |
04-09-2024 | $3.93 | $3.53 | $3.93 | $3.47 | 47,568 | 5,862 | 12.32% |
04-08-2024 | $3.8 | $3.97 | $3.97 | $3.7701 | 13,359 | 4,049 | 30.31% |
04-05-2024 | $3.94 | $3.88 | $3.94 | $3.75 | 24,657 | 4,616 | 18.72% |
04-04-2024 | $3.9 | $3.89 | $4.04 | $3.82 | 24,760 | 8,892 | 35.91% |
News, Short Squeeze, Breakout and More Instantly...
NeuroBo Pharmaceuticals Inc. Company Name:
NRBO Stock Symbol:
NASDAQ Market:
NeuroBo to Present Latest Pre-Clinical Data on Cardiometabolic Assets, DA-1241 and DA-1726, Targeting MASH and Obesity, at Scientific Conferences in June PR Newswire CAMBRIDGE, Mass. , April 30, 2024 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO...
NeuroBo Pharmaceuticals Doses First Patient in Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity PR Newswire Phase 1 Clinical Trial Timelines Significantly Accelerated Top-Line Data Readout from Single Ascending Dose Part 1 Now Expected in the ...
NeuroBo Pharmaceuticals Completes Enrollment of Part 1 of Its Phase 2a Clinical Trial Evaluating DA-1241 for the Treatment of MASH PR Newswire Full Data Readout Expected in the Second Half of 2024 CAMBRIDGE, Mass. , April 1 , 2024 /PRNewswire/ -- Neur...